Europe Vascular Imaging Market

Europe Vascular Imaging Market Size & Growth (2023 to 2028):

The size of the Vascular Imaging market in Europe was valued at USD 1.36 billion in 2023 and is poised to reach USD 1.86 billion by the end of 2028, to grow a 6.43% CAGR during the forecast period 2023 to 2028.

The European vascular imaging market is driven by the rising prevalence of cardiovascular diseases and the rising demand for minimally invasive diagnosis and treatment.

In addition, growing awareness among the people about the early diagnosis and intervention to prevent mortality or morbidity, increasing healthcare spending, and favorable reimbursement policies are fueling the market growth. 

The growing senior population is one of the primary growth factors of the market. Older people are associated with chronic conditions such as diabetes, hypertension, cancer, and other lung diseases. 

Technological advancements in vascular imaging systems are expected to boost market growth. Rapid advances in noninvasive imaging technologies significantly influence the diagnosis of cardiovascular diseases (CVDs), the development of appropriate medicines and prognosis, lowering healthcare costs/expenditure, and delivering value-based care. Furthermore, significant advances in MRI methods capable of monitoring biological processes such as inflammation, neovascularization, and mechanical pressures might help researchers better comprehend atherothrombotic disease.

Moreover, the increasing investments and funding by the government for the development of healthcare infrastructure development and favorable reimbursement policies are fueling the market's growth.

Furthermore, the market strategies adopted by the key market players to expand the regional market growth are strengthening the market growth. The techniques include partnerships, mergers, and acquisitions. 

However, alternative conventional low-cost imaging procedures for cardiovascular diseases are limiting the market growth.  

Furthermore, the high cost of vascular imaging and a lack of competence in operating the equipment may limit the growth of the worldwide vascular imaging market.

This research report on the Europe Vascular Imaging Market has been segmented and sub-segmented into the following categories.

By Technology:

• CT
• MRI
• X-Ray
• Ultrasound
• Nuclear Imaging

By Procedure:

• Coronary Angiography
• Peripheral
• Cerebral Angiography

By Application:

• Diagnostic
• Therapeutic

By End User:

• Hospital
• Diagnostic Center

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, Europe holds the second-largest share of the global vascular imaging market and is projected to witness a significant share during the period. Streamlined reimbursement policies, availability of advanced healthcare infrastructure, and key market players boost the market growth. 

The German vascular imaging market held most of the market share over the forecast period. The high prevalence of cardiovascular disorders, technological advancements in the healthcare sector, and supportive government policies and investments are escalating the vascular imaging market in the country. 

The U.K Vascular imaging market is projected to witness a considerable share due to the increasing burden of CVDs, the growing geriatric population, and the rising demand for minimally invasive diagnosis and treatments. 

The France vascular imaging market and Spain vascular imaging market are predicted to showcase a promising share globally owing to the increasing number of government initiatives, technological advancements in vascular imaging and growing awareness, availability of advanced treatment procedures in these countries, and rising disposable income of the individuals contribute to the regional market growth.

KEY MARKET PLAYERS

Key players dominating in the Europe Vascular Imaging Market profiled in this report are Siemens Healthineers (Germany), GE Healthcare (U.K.), Xograph Healthcare (U.K.), and Piur imaging GmbH (Austria), N.V. (Netherlands), Pie Medical Imaging (Netherlands), Esaote SpA (Italy)